Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

August 6, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Apicomplexan parasites found sneak-peeking in human cells while gliding using molecular legs of host muscle protein

IISER Pune Epigenetics Project Recruitment | Life Sciences Apply

The stethoscope: A new transmitter of COVID-19?

Apicomplexan parasites found sneak-peeking in human cells while gliding using molecular legs of host muscle protein
  • BiotechToday
  • World

Apicomplexan parasites found sneak-peeking in human cells while gliding using molecular legs of host muscle protein

bioxone October 15, 2020October 15, 2020

Sristi Raj Rai, Amity University Kolkata

Wanderers outside our body are in search of nutrients and host to persist and multiply to survive on the planet. Obligate endoparasite of Apicomplexa phylum invades human – intermediate/secondary hosts. These single-celled eukaryotes are of high medical and agricultural importance. Members such as Toxoplasma gondii and Plasmodium falciparum can glide without changing its structure along the surface of human skin cells surprisingly, entering into the blood vessels. Plasmodium species results in 414,000 deaths per year due to malaria infection. Toxoplasma is solely responsible for toxoplasmosis infection of 30% of the population across the world with compromised immunity and in pregnant women. 

Gliding motility efficiently utilizes actin-myosin motor present in vertebrates for cell invasion leading to proliferation, migration, and transmission. The parasitic anchor for the motor is located in the intermembrane space between the plasma membrane and inner membrane complex (IMC) – an extra layer unique to these intracellular organisms. Myosin protein interacts with several proteins from the parasitic system forming dynamic macromolecular machinery known as glideosome. Incomplete information about glideosome functioning and molecular mechanisms due to lack of structural data hindered the understanding of the apicomplexan gliding and invasion complexes. Scientists from Germany took the pain of analyzing the molecular structure of a glideosome member-protein – essential light chains (ELCs) found in T. gondii (TgELC1 and TgELC2) and P. falciparum (PfELC) by using X-ray crystallography and nuclear magnetic resonance (NMR).  

Studies revealed IMC with the help of three glideosome-associated proteins (GAPs) gets linked to small unconventional myosin protein (MyoA) to which myosin light chain (MLC1) and ELC binding takes place and stabilizes it. After the completion of Ca-independent assembly, ELCs undergo compression forming α helix thereby, stiffening the MyoA to act as lever arms enabling it to take longer leaps and doubling its speed, ready to empower parasitic motility. Preventing the assembly of the glideosome by mutating the phosphorylation sites can decrease the binding affinity of ELCs and thus can stop the progression of diseases with the help of drugs. 

Also read: Osteocyte Apoptosis: Resorption-Related bone diseases

SOURCE – Pazicky, S., Dhamotharan, K., Kaszuba, K., Mertens, H., Gilberger, T., Svergun, D., Kosinski, J., Weininger, U. and Löw, C., 2020. Structural role of essential light chains in the apicomplexan glideosome. Communications Biology, 3(1).https://doi.org/10.1038/s42003-020-01283-8

  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged Actin Amicomplexa Cell Biology Essential light chains (ELCs) Glideosome Gliding Molecular biology Myosin Nuclear magnetic resonance (NMR) Obligate endoparasite Plasmodium falciparum Toxoplasma gondii X-ray crystallography

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

The stethoscope: A new transmitter of COVID-19?

bioxone October 15, 2020

–PRIYANKA CHAKRABORTY, AMITY UNIVERSITY, KOLKATA The stethoscope, primarily known as the “third hand” of the medical providers, surfaced as a potential vector of COVID-19 after several studies were made.  It is believed that since a stethoscope plays an integral role between a patient and a provider and can possess as many microbes as present in […]

stethoscope

Related Post

  • BiotechToday
  • World

A novel approach to reduce graft-vs-host disease

bioxone July 17, 2021July 16, 2021

Monika R, PSG College of Technology, Coimbatore Stem cell transplantation (SCT) has emerged as the treatment of choice for most people suffering from disorders of the hematopoietic and immune systems or cancer. Each year, 12,000-15,000 allogeneic SCTs are estimated worldwide, with a continuing growth rate of 10-20% per year.  Allogeneic SCT is a medical procedure […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Plasmodium falciparum Acetyl-CoA Synthetase as a target for Malaria treatment

bioxone August 11, 2021August 10, 2021

Srabani Roy Chowdhury (MAKAUT, WB) Despite all the global malaria control measures, more than a 200million malaria cases are seen, out of which 0.5million people have succumbed to death. The attempts for new drugs have led to the identification of various chemical compounds that can destroy the parasites in the different stages of their life […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Biomarker TIICs benefitting the prognosis in osteosarcoma patients

bioxone October 29, 2020October 28, 2020

Rohit Bhattacharjee, Amity University, Kolkata Osteosarcoma is a rare malignant bone tumour found in adults and children. It is characterized by early lung metastasis and poor prognosis that seriously the physical and mental health of patients. Chemotherapy and surgery include the main clinical treatment however, recurrence of metastasis remains the poor prognosis. Advances in the […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy